In this episode, Biorasi CEO Chris O’Brien hosted scientist and entrepreneur Daniel J. Mandell, Ph.D. to discuss how his creativity and imagination led him on a journey to developing the foundational work on genomically recoded organisms (GROs) at Harvard Medical School, and how expanding the amino acid alphabet for groundbreaking protein-based therapies holds the promise of treating incurable diseases.
